Brain-Derived Neurotrophic Factor Serum Levels in Alcohol-Dependent Subjects 6 Months After Alcohol Withdrawal

被引:60
作者
Costa, Marie-Agnes [1 ,2 ]
Girard, Murielle [1 ]
Dalmay, Francois [3 ]
Malauzat, Dominique [1 ]
机构
[1] Ctr Hosp Esquirol, Dept Rech & Dev, F-87025 Limoges, France
[2] Ctr Hosp Esquirol, Lab Anal Biol, F-87025 Limoges, France
[3] CHU Limoges, Unite Fonct Rech Clin & Biostat, Limoges, France
关键词
BDNF; Alcohol Dependence; Withdrawal; Neuronal Plasticity; NERVE GROWTH-FACTOR; FACTOR BDNF; HOMEOSTATIC PATHWAY; HUMAN PLATELETS; USE DISORDERS; DEPRESSION; EXPRESSION; CELLS; RECEPTORS; RELAPSE;
D O I
10.1111/j.1530-0277.2011.01548.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Diagnosing alcohol dependence is based on clinical signs and on the measured levels of biological markers of alcohol consumption. However, these markers are neither sufficiently sensitive and nor specific enough to definitively determine alcohol dependence. The neuro-adaptive changes associated with alcohol dependence involve markers such as brain-derived neurotrophic factor (BDNF), which regulate neuronal plasticity. Serum levels of BDNF have been reported to decrease during alcohol dependence and may be restored to normal soon after alcohol is withdrawn. However, the long-term relationship between serum BDNF levels and abstinence status is unknown. Methods: We investigated serum BDNF levels in 101 abstinent and relapsing alcohol-dependent subjects at the moment of hospitalization for alcohol withdrawal (M0) and 6 months later (M6) and compared them to the serum BDNF levels of 41 nondependent subjects. The BDNF levels of the alcohol-dependent subjects were compared to their serum gamma glutamyl transferase (GGT) levels, mean corpuscular volume (MCV) values, and their score on the Beck Depression Inventory (BDI) questionnaire. Results: Forty-four percent of the alcohol-dependent participants remained abstinent during the 6 months following alcohol detoxification. Serum BDNF levels of the abstinent group at M6 were significantly higher than those of the original group of alcohol-dependent subjects at M0 (p = 0.034). Only the abstinent group had higher BDNF levels than the control group (p < 0.001). Serum BDNF levels increased to a greater extent in the abstinent group than in the nonabstinent group (p = 0.016). No correlations were found between serum BDNF levels and GGT level, MCV value, or BDI score. Conclusions: Our data confirm that serum BDNF levels do not correlate with either chronic alcohol consumption or peripheral toxicity but may be linked to neuronal aspects of alcohol consumption and dependence. The increased serum levels of BDNF may reflect the concomitant activation of BDNF synthesis that accompanies the neuronal remodeling triggered by alcohol withdrawal and suggests that BDNF synthesis may have a role in the long-term maintenance of abstinence. Monitoring the serum BDNF levels of alcoholics undergoing treatment could help to characterize alcohol dependence profiles and predict relapse.
引用
收藏
页码:1966 / 1973
页数:8
相关论文
共 50 条
  • [21] Brain-derived neurotrophic factor serum levels as a candidate biomarker for withdrawal in crack heroin dependence
    Gorgich, Enam Alhagh Charkhat
    Rigi, Mohammad Gol
    Fanaei, Hamed
    Parsaei, Houman
    Ghanbarzehi, Abdolhakim
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2024, 19 (01)
  • [22] Determinants of serum brain-derived neurotrophic factor
    Bus, B. A. A.
    Molendijk, M. L.
    Penninx, B. J. W. H.
    Buitelaar, J. K.
    Kenis, G.
    Prickaerts, J.
    Elzinga, B. M.
    Voshaar, R. C. Oude
    PSYCHONEUROENDOCRINOLOGY, 2011, 36 (02) : 228 - 239
  • [23] Serum brain-derived neurotrophic factor levels were reduced during methamphetamine early withdrawal
    Chen, Pao-Huan
    Huang, Ming-Chi
    Lai, Ying-Ching
    Chen, Po-Yu
    Liu, Hsing-Cheng
    ADDICTION BIOLOGY, 2014, 19 (03): : 482 - 485
  • [24] Time-Dependent Serum Brain-Derived Neurotrophic Factor Decline During Methamphetamine Withdrawal
    Ren, Wenwei
    Tao, Jingyan
    Wei, Youdan
    Su, Hang
    Zhang, Jie
    Xie, Ying
    Guo, Jun
    Zhang, Xiangyang
    Zhang, Hailing
    He, Jincai
    MEDICINE, 2016, 95 (05) : 1 - 5
  • [25] Evolution of BDNF serum levels during the first six months after alcohol withdrawal
    Girard, Murielle
    Labrunie, Anais
    Malauzat, Dominique
    Nubukpo, Philippe
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2020, 21 (10) : 739 - 747
  • [26] Decreased plasma brain-derived neurotrophic factor levels in patients with alcohol dependence
    Joe, Keun-Ho
    Kim, Yong-Ku
    Kim, Tae-Suk
    Roh, Sung-Won
    Choi, Sam-Wook
    Kim, Young-Bo
    Lee, Hee-Jin
    Kim, Dai-Jin
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2007, 31 (11) : 1833 - 1838
  • [27] Brain-derived neurotrophic factor levels and depression during methamphetamine withdrawal
    Ren, Wenwei
    Luan, Xiaoqian
    Zhang, Jie
    Gutteea, Priyanka
    Cai, Yan
    Zhao, Jiyun
    Gu, Yingying
    Wu, Chaowen
    Su, Hang
    Tao, Jingyan
    Xie, Ying
    Lv, Dezhao
    Feng, Liang
    He, Jincai
    JOURNAL OF AFFECTIVE DISORDERS, 2017, 221 : 165 - 171
  • [28] Differential Patterns of Serum Brain-Derived Neurotrophic Factor Levels in Alcoholic Patients With and Without Delirium Tremens During Acute Withdrawal
    Huang, Ming-Chyi
    Chen, Chun-Hsin
    Liu, Hsing-Cheng
    Chen, Chiao-Chicy
    Ho, Chia-Chen
    Leu, Sy-Jye
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2011, 35 (01) : 126 - 131
  • [29] Serum inflammatory molecules and markers of neuronal damage in alcohol-dependent subjects after withdrawal
    Girard, Murielle
    Malauzat, Dominique
    Nubukpo, Philippe
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2019, 20 (01) : 76 - 90
  • [30] Brain-derived neurotrophic factor serum levels in cocaine-dependent patients during early abstinence
    Corominas-Roso, Margarida
    Roncero, Carlos
    Jose Eiroa-Orosa, Francisco
    Gonzalvo, Begona
    Grau-Lopez, Lara
    Ribases, Marta
    Rodriguez-Cintas, Laia
    Sanchez-Mora, Cristina
    Ramos-Quiroga, Josep-Antoni
    Casas, Miguel
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (09) : 1078 - 1084